Search results
The Zacks Analyst Blog Highlights Eli Lilly, Sanofi Merck, AstraZeneca's and Roche
Zacks via Yahoo Singapore Finance· 14 hours agoThe option exercise will convert the co-exclusive license into an exclusive global license for Merck...
Roche's New Immunotherapy Fails To Show Benefit Over Merck's Blockbuster Keytruda In Lung Cancer...
Benzinga via Yahoo Singapore Finance· 3 days agoOn Thursday, Roche Holdings AG (OTC:RHHBY) said that the Phase 2/3 SKYSCRAPER-06 study of...
Merck (NYSE:MRK) Seems To Use Debt Quite Sensibly
Simply Wall St. via Yahoo Singapore Finance· 5 days agoWhat we care about is avoiding the permanent loss of capital.' It's only natural to consider a company's balance sheet when you examine how risky it is,...
Factbox-Stocks to watch as Biden and Trump vie for presidency
Reuters via Yahoo Singapore Finance· 5 days agoM&A-RELATED BENEFICIARIES...lost exports amid the trade war. These initiatives could help...
mRNA Technology Promises To Make A Long-Time Coming Turning Point In Cancer Treatment
Benzinga via Yahoo Singapore Finance· 6 days agoModerna Inc (NASDAQ: MRNA) and Merck & Co (NYSE: MRK) joined forces to advance cancer treatment with...
As the AI boom gobbles up power, Phaidra is helping companies manage datacenter power more...
TechCrunch via Yahoo News Singapore· 6 days agoIn a May 2024 report, Goldman Sachs predicted that data centers will use 8% of the U.S.'s total...
Merck (MRK) Gets Exclusive Rights to Opevesostat From Partner
Zacks via Yahoo Singapore Finance· 6 days agoMerck (MRK) exercises the option that will convert the collaboration deal with partner Orion for...